AMEX · Analyst Forecast

Nasus Pharma Ltd. (NSRX) Stock Forecast & Price Target

$2.55 AMEX: NSRX Market Cap $21.96M

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Nasus Pharma Ltd. (NSRX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Nasus Pharma Ltd., the average estimate for 2030 earnings per share is 0.73; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$2.55
Consensus targetThe average of the price targets analysts have published.$22.00
Median targetThe middle target, less affected by a single outlier.$22.00
Highest targetThe most optimistic published target.$22.00
Lowest targetThe most pessimistic published target.$22.00
Difference from priceHow far the consensus target sits from today’s price.+762.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (reporting currency)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
20250002
20260002
20270002
20283.52M3.52M3.52M1
202915.07M15.07M15.07M1
203033.50M33.50M33.50M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−0.95−0.69−0.422
2026−1.13−1.13−1.132
2027−1.10−1.10−1.102
2028−0.65−0.65−0.651
2029−0.12−0.12−0.121
20300.730.730.731

Nasus Pharma Ltd. (NSRX) forecast — frequently asked questions

What is the analyst price target for Nasus Pharma Ltd.?

Analysts covering Nasus Pharma Ltd. (NSRX) have a consensus price target of $22.00, 762.7% above the current price of $2.55. Published targets range from $22.00 to $22.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Nasus Pharma Ltd.'s earnings?

The average analyst estimate for Nasus Pharma Ltd. (NSRX) earnings per share in 2030 is 0.73, with individual estimates between 0.73 and 0.73.

How much revenue is Nasus Pharma Ltd. expected to make?

Analysts forecast Nasus Pharma Ltd. (NSRX) revenue of 33.50M in 2030, based on 1 published estimates.

How many analysts cover NSRX?

2 analysts contribute estimates for Nasus Pharma Ltd. (NSRX). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Pharmaceuticals stocks

RPRX forecastCORT forecastLQDA forecastPBH forecastQUIT forecastHITI forecastAll Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.